MedPath

Comparing the effectiveness of four transdiagnostic among adults and adolescences

Not Applicable
Recruiting
Registration Number
IRCT20231106059970N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
360
Inclusion Criteria

Age between 11-18 in adolescence sample
Age between 18 to 65 in adults group
Be able to read and speak Farsi fluently,
participant in in-person psychotherapy sessions
Adolescence sample meet full criteria for at least one emotional disorders
In Adult sample: meet full criteria for at least one emotional disorders and /or cluster B personality disorders

Exclusion Criteria

active suicidal plan
substance dependency,
meet criteria as schizophrenia and neurological diseases
psychiatry medicines
miss more than three psychotherapy session repeatedly

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scores of Beck's Depression Inventory (BDI-II). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's Depression Inventory (BDI-II).;Scores of Beck's anxiety Inventory (BAI). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's anxiety Inventory (BAI).;Scores of the Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004).;Scores of the Positive and Negative Affect Schedule (PANAS). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Positive and Negative Affect Schedule (PANAS) (Watson, Clark, & Tellegen, 1988).
Secondary Outcome Measures
NameTimeMethod
Scores of Shame severity. Timepoint: baseline, post- treatment, 6,12,18,24 and 36 months follow-up. Method of measurement: The Experience of Shame Scale (ESS, Andrews et al, 2002).
© Copyright 2025. All Rights Reserved by MedPath